BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.81% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3651
Artesian Resources
ARTNA
$348M
| $7.12M | ﹤0.01% |
209,332
+38,635
| +23% | +$1.25M |
2016 Q1
41 quarters
|
|
3652
XPLR Infrastructure LP
XIFR
$690M
| $7.08M | ﹤0.01% |
599,299
+11,752
| +2% | +$131K |
2014 Q3
47 quarters
|
|
3653
PLDT
PHI
$3.91B
| $7.06M | ﹤0.01% |
402,746
-440,527
| -52% | -$8.52M |
2021 Q1
21 quarters
|
|
3654
ReposiTrak
TRAK
$130M
| $7.05M | ﹤0.01% |
783,702
+87,169
| +13% | +$797K |
2016 Q1
41 quarters
|
|
3655
Riverview Bancorp
RVSB
$122M
| $7.04M | ﹤0.01% |
1,296,799
-1,080,369
| -45% | -$5.98M |
2017 Q1
37 quarters
|
|
3656
Pebblebrook Hotel Trust 6.3% Series F Preferred Shares
PEB.PRF
$120M
| $7M | ﹤0.01% |
360,272
-42,852
| -11% | -$857K |
2025 Q1
5 quarters
|
|
3657
iShares S&P 100 ETF
OEF
$19.9B
| $6.95M | ﹤0.01% |
18,995
+2,168
| +13% | +$777K |
2015 Q4
42 quarters
|
|
3658
1stdibs.com
DIBS
$197M
| $6.93M | ﹤0.01% |
1,415,255
+1,124,607
| +387% | +$5.42M |
2021 Q2
20 quarters
|
|
3659
iShares MSCI Philippines ETF
EPHE
$144M
| $6.9M | ﹤0.01% |
285,473
-20,748
| -7% | -$515K |
2024 Q2
8 quarters
|
|
3660
i-80 Gold Corp
IAUX
$1.29B
| $6.87M | ﹤0.01% |
4,769,118
-343,371
| -7% | -$530K |
2023 Q2
12 quarters
|
|
3661
OnKure Therapeutics
OKUR
$131M
| $6.84M | ﹤0.01% |
1,499,845
+1,450,258
| +2,925% | +$6.22M |
2021 Q2
20 quarters
|
|
3662
BRC Inc
BRCC
$253M
| $6.83M | ﹤0.01% |
615,153
+38,773
| +7% | +$480K |
2022 Q1
17 quarters
|
|
3663
Schwab US Dividend Equity ETF
SCHD
$121B
| $6.81M | ﹤0.01% |
214,741
+45,992
| +27% | +$1.46M |
2015 Q4
42 quarters
|
|
3664
Schwab U.S Small- Cap ETF
SCHA
$22.3B
| $6.8M | ﹤0.01% |
188,308
+67,037
| +55% | +$2.22M |
2015 Q4
42 quarters
|
|
3665
Standard BioTools
LAB
$274M
| $6.79M | ﹤0.01% |
8,254,443
-16,501,641
| -67% | -$15.6M |
2013 Q2
52 quarters
|
|
3666
Beyond Meat
BYND
$112M
| $6.75M | ﹤0.01% |
300,143
-653,546
| -69% | -$15.2M |
2019 Q2
28 quarters
|
|
3667
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$111M
| $6.74M | ﹤0.01% |
212,121
-33,194
| -14% | -$1.07M |
2021 Q4
18 quarters
|
|
3668
Artiva Biotherapeutics
ARTV
$206M
| $6.74M | ﹤0.01% |
694,726
+481,338
| +226% | +$4.38M |
2024 Q3
7 quarters
|
|
3669
Acumen Pharmaceuticals
ABOS
$17.1M
| $6.65M | ﹤0.01% |
2,490,115
+2,311,789
| +1,296% | +$5.71M |
2021 Q3
19 quarters
|
|
3670
Unicycive Therapeutics
UNCY
$103M
| $6.63M | ﹤0.01% |
1,413,381
+1,377,478
| +3,837% | +$10.2M |
2025 Q3
3 quarters
|
|
3671
Hanover Bancorp
HNVR
$152M
| $6.62M | ﹤0.01% |
283,884
+56,688
| +25% | +$1.3M |
2022 Q3
15 quarters
|
|
3672
INNOVATE Corp
VATE
$73.9M
| $6.62M | ﹤0.01% |
354,408
+263,360
| +289% | +$3.58M |
2016 Q1
41 quarters
|
|
3673
Venu Holding Corp
VENU
$66.7M
| $6.57M | ﹤0.01% |
2,894,402
+2,467,133
| +577% | +$8.83M |
2025 Q3
3 quarters
|
|
3674
TMC The Metals Company
TMC
$1.16B
| $6.56M | ﹤0.01% |
1,479,956
+239,120
| +19% | +$1.25M |
2023 Q3
11 quarters
|
|
3675
Gyre Therapeutics
GYRE
$509M
| $6.55M | ﹤0.01% |
993,943
+235,313
| +31% | +$1.6M |
2017 Q1
37 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 244 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 244 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.